Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to -$35.4 million.

  • Pediatrix Medical's Cash from Investing Activities rose 25223.61% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year increase of 6886.09%. This contributed to the annual value of -$35.4 million for FY2024, which is 2650.7% up from last year.
  • Latest data reveals that Pediatrix Medical reported Cash from Investing Activities of -$35.4 million as of FY2024, which was up 2650.7% from -$48.2 million recorded in FY2023.
  • Pediatrix Medical's 5-year Cash from Investing Activities high stood at $815.5 million for FY2020, and its period low was -$57.0 million during FY2022.
  • Over the past 5 years, Pediatrix Medical's median Cash from Investing Activities value was -$48.2 million (recorded in 2023), while the average stood at $123.9 million.
  • Per our database at Business Quant, Pediatrix Medical's Cash from Investing Activities soared by 69596.99% in 2020 and then crashed by 10679.61% in 2021.
  • Over the past 5 years, Pediatrix Medical's Cash from Investing Activities (Annual) stood at $815.5 million in 2020, then plummeted by 106.8% to -$55.4 million in 2021, then dropped by 2.76% to -$57.0 million in 2022, then grew by 15.41% to -$48.2 million in 2023, then increased by 26.51% to -$35.4 million in 2024.
  • Its Cash from Investing Activities was -$35.4 million in FY2024, compared to -$48.2 million in FY2023 and -$57.0 million in FY2022.